Considerations For The Safe and Effective Use of Iron Interventions In Context of Malaria and Its Co-morbidities (U01)

The summary for the Considerations For The Safe and Effective Use of Iron Interventions In Context of Malaria and Its Co-morbidities (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Considerations For The Safe and Effective Use of Iron Interventions In Context of Malaria and Its Co-morbidities (U01)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HD-09-029
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Apr 17, 2009
	Creation Date:	Apr 17, 2009
	Original Closing Date for Applications:	Jun 19, 2009
	Current Closing Date for Applications:	Jun 19, 2009
	Archive Date:	Jul 20, 2009
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$1,100,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose. The goal of this FOA, which represents part of a larger partnership between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, the NIH Office of Dietary Supplements (ODS), and the Bill and Melinda Gates Foundation, is to generate new data to support improved programs to prevent and treat iron deficiency in areas of endemic infection, particularly malaria. To achieve this goal the FOA is intended to solicit high-quality research projects to fill urgent knowledge gaps regarding the safety of interventions to prevent and treat iron deficiency. Projects should be designed to answer any of the following core questions: 1) what are the key mechanisms by which iron status and interventions that may impact on that status can influence the immune system and response to infections such as malaria? 2) what are the most sensitive and specific indicators of iron status that can be used in resource-limited settings, and what are the most appropriate biomarkers of iron status and disease outcome? and 3) what are the safest and most effective interventions to prevent and treat iron deficiency in areas of endemic malaria? Mechanism of Support. This FOA will utilize the Cooperative Research (U01) grant mechanism. Funds Available and Anticipated Number of Awards. The NICHD intends to commit approximately $1.1 million to support 3 to 6 awards in FY 2009.The ODS will provide additional support to one or more meritorious grants that address any of the three core areas, i.e., mechanisms, biomarkers or safety/efficacy studies, consistent with ODS mission and contingent on availability of funds. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.The total amount awarded and the number of awards will depend upon the quality, duration, the need to have applications representing each of the core objectives of the initiative (i.e., mechanisms, biomarkers, and interventions), and costs of the applications received. Budget and Project Period.For any given application, budgets for total costs of up to $200,000 per year and a project duration of up to 4 years may be requested for a maximum of $800,000 total costs over a four-year project period.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-hd-09-029.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION